US 11472889
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 11472889 (Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00